Quarterly Sales and EPS Roundup:
UnitedHealth Group Incorporated (UNH) reported sales (ttm) of 192.6 Billion, whereas, 12 number of analysts estimated the mean sale of 50389.2 million. The analysts estimated sales for the higher end at 50846.5 million and lower end at 49948 million while the year ago reported sale was 49029.5 million.
12 number of analysts have estimated the sales of the company for the quarter, analysts estimated mean sale target of 51411.1 million while high and low sale targets are estimated at 52174 million and 50786.4 million respectively.
UnitedHealth Group Incorporated (UNH) reported earning per shares for the quarter ending Jul 18 BMO, whereas, 18 number of analysts estimated the mean EPS at 2.56. The analysts estimated EPS for the higher end at 2.61 and lower end at 2.47 while the year ago reported earnings per share was 2.42.
The company has mean EPS estimate of 2.49 reported by 18 number of analyst for the quarter ending Current Qtr.(Sep2017). The analysts estimated mean EPS at 2.49 while the high and low EPS estimate stand at 2.6 and 2.44 respectively. In contrast to the year ago quarter EPS was at 2.36. EPS long term mean growth rate estimated by 8 analysts is at 14.95%, whereas, the high and low Long term growth rate estimated at 21 and 10.
Valuation Ratios of UnitedHealth Group Incorporated (UNH) versus the Industry and Sector:
Let’s have a look at some of the important valuation ratios of the UnitedHealth Group Incorporated (UNH). These ratios are important while doing valuation of the company or the shares of the company.
UnitedHealth Group Incorporated (UNH) currently has P/E (Price to Earnings) ratio of 23.43 while the company’s industry has 22.95 P/E and the sector P/E is 33.54. Similarly, the company’s last 5 years high P/E ratio is 22.08 and low P/E is 10.27, whereas, the industry’s and sector’s high P/E for the past year is 23.02 and 44.26 respectively and low P/E ratio for the last 5 years is 9.62 for the industry and 24.62 for the Sector.
Beta is also an important valuation ratio for analyzing the stock of the company, UNH has Beta of 0.64 while its industry and Sector’s beta remains at 0.64 and 0.95 respectively.
Price to Sale ratio of UNH stands at 0.98 while Price to Book Ratio stands at 4.36. Its Price to Cash Flow ratio shows the value of 18.19, whereas, the industry and sector ratio of Price to Cash Flow ticked at 17.81 and 24.54 respectively.
5 Year Growth Rate Analysis:
Growth rates are very important while analyzing the long term growth and valuation of a certain company.
5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of UnitedHealth Group Incorporated (UNH) stands at 12.66 while the industry’s and the sector’s growth for next 5 years ticked at 12.37 and 10.56 respectively. The company’s 5 year Earnings per share growth and Capital Spending growth remains at 8.91 and 9.83.
UnitedHealth Group Incorporated (UNH) Trading Statistics:
The company declined -1.16% and closed its last trading session at $194.83. The market capitalization of the company is at $185.47 Billion. The stock touched 52-week High of $196.04 on 08/04/17 and 52-week Low of $132.39 on 09/12/16. The stock currently has Weekly Volatility of 0.73% and Monthly Volatility of 1.04%. The Beta for the company stands at 0.64 and its Average True Range (ATR) shows a value of 1.93.